参考文献/References:
[1] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2022)[J].中华骨质疏松和骨矿盐疾病杂志,2022,15(6):573-611.
[2] LANE N E.Epidemiology,etiology,and diagnosis of osteoporosis[J].Am J Obstet Gynecol,2006,194(2 Suppl):S3-S11.
[3] 中国老年保健医学研究会老年疼痛疾病分会.老年骨质疏松性疼痛诊疗与管理中国专家共识(2024版)[J].中国疼痛医学杂志,2024,30(4):241-250.
[4] 芦佳劲,齐保玉,金子开,等.补肾健脾活血方药治疗原发性骨质疏松症的研究进展[J].中国中医基础医学杂志,2024,30(3):556-562.
[5] 施彩星.补肾健脾活血法治疗老年骨质疏松症患者的临床研究[D].南京:南京中医药大学,2024.
[6] 宋佳,高晓霞,田俊生,等.中药药对配伍机制的现代研究[J].中草药,2017,48(21):4367-4374.
[7] 王庆谚,李佳,郑洪新.从“肾虚络病,瘀阻骨络”探讨原发性骨质疏松症中医病机[J].中华中医药杂志,2022,37(2):756-759.
[8] 中华中医药学会.骨质疏松性骨折中医诊疗指南[J].中医正骨,2023,35(1):1-9.
[9] 董怡,陈佳俊,陈奇耀,等.沈钦荣基于“不荣则痛”理论治疗慢性筋骨病经验[J].浙江中医杂志,2024,59(1):23-24.
[10] 高伟,郭爽.论“不通则痛”[J].河南中医,2012,32(11):1445.
[11] 李新春,胡万钧,甘发荣,等.杜仲-续断药对通过调控铁死亡途径对去卵巢骨质疏松症大鼠的保护作用及机制研究[J].中华中医药学刊,2023,41(9):103-106.
[12] 秧荣昆,关智宇.基于肾主骨理论探讨杜仲通过调控OPG/RANKL/RANK通路对去势骨质疏松大鼠的影响[J].中成药,2023,45(1):70-74.
[13] 张强,张敏,黄志荣,等.续断皂苷VI调控Wnt/β-Catenin通路对骨质疏松的影响机制[J].世界科学技术-中医药现代化,2022,24(6):2245-2254.
[14] 郭德华,夏自成,吴成林,等.基于“肝肾同源”理论探究杜仲-续断药对治疗绝经后骨质疏松症的临床疗效[J].时珍国医国药,2023,34(11):2688-2690.
[15] JOHNSTON C B,DAGAR M.Osteoporosis in older adults[J].Med Clin North Am,2020,104(5):873-884.
[16] 邹艺璇.杜仲-续断药对促进骨质疏松骨折愈合的作用机制研究[D].济南:山东中医药大学,2023.
[17] 汪选斌,刘洪涛,吕海涛.何首乌的传统与现代研究[M].上海:上海交通大学出版社,2021:8-9.
[18] GONG L,SHEN X,HUANG N,et al.Research progress on hepatotoxicity mechanism of polygonum multiflorum and its main components[J].Toxicon,2024,248:108040.
[19] 李宇栋,吴承东,许云霞,等.吕培文教授运用药对治疗中医外科疾病经验撷英[J].现代中医临床,2023,30(5):107-112.
[20] XIONG H,HUANG T Y,CHANG Y L,et al.Achyranthes bidentate extracts protect the IL-1β-induced osteoarthritis of SW1353 chondrocytes[J].J Biosci Bioeng,2023,136(6):462-470.
[21] SHI L,REN L,LI J,et al.Ethanol extract of Cyathulae Radix inhibits osteoclast differentiation and bone loss[J].Chin J Nat Med,2024,22(3):212-223.
[22] 韩艺杰,袁开智,王冰,等.何首乌-牛膝药对抗维甲酸诱导骨质疏松作用及活性成分筛选研究[J].中华中医药学刊,2024,42(7):255-258.
[23] 陈士铎.本草新编[M].柳长华,徐春波,校注.北京:中国中医药出版社,1996:60-64.
[24] PATEL D K.Biological importance,therapeutic benefits,andanalytical aspects of active flavonoidal compounds‘Corylin'from psoralea corylifolia in the field of medicine[J].Infect Disord Drug Targets,2023,23(1):e250822208005.
[25] 钟楚婷,韩亮,钟颖儿,等.炙淫羊藿炮制工艺及抗骨质疏松作用[J].广东药科大学学报,2024,40(5):36-42.
[26] 刘琪,李林臻,张君涛.淫羊藿苷促进关节软骨损伤修复作用机制研究进展[J].药物评价研究,2024,47(6):1393-1399.
[27] 杨岩冰,郭云鹏,柴爽.补骨脂-淫羊藿药对抗绝经后骨质疏松症的网络药理学分析[J].西部中医药,2023,36(10):35-39.
[28] 杨岩冰,曾英,李劲平,等.补骨脂-淫羊藿药对对去卵巢骨质疏松型大鼠血清IL-10、TNF-α水平的影响[J].湖南中医杂志,2016,32(3):159-161.
[29] 王景霞,陈卫衡,陈绍红,等.基于“异病同治”理论探讨恒古骨伤愈合剂在4种骨伤科疾病治疗中的应用[J].中医正骨,2021,33(3):34-39.
[30] 刘耀晨,张铁军,郭海彪,等.三七的研究进展及其质量标志物预测分析[J].中草药,2021,52(9):2733-2745.
[31] 高文鑫,陈云刚,姚康,等.骨碎补治疗骨质疏松症的实验研究进展[J].中国骨质疏松杂志,2022,28(11):1683-1689.
[32] 刘博,丁龙龙,陈志健,等.骨碎补及其活性成分防治骨质疏松症的作用机制[J].中国骨质疏松杂志,2024,30(10):1540-1547.
[33] 杨雯静,黄健,王维,等.基于网络药理学和体外细胞实验探究“三七-骨碎补”药对活性成分治疗骨质疏松症的作用机制[J].中国中药杂志,2023,48(4):1087-1097.
[34] 李芬.丹红注射液治疗深静脉血栓形成的临床观察[J].中国中医急症,2015,24(3):551-552.
[35] 熊义博.中药丹参治疗骨质疏松的作用及其机制[J].医学信息,2020,33(9):44-46.
[36] WANG Y,LI X,DENG F,et al.Hydroxy-safflower yellow a alleviates osteoporosis in ovariectomized rat model by inhibiting carbonic anhydrase 2 activity[J].Front Pharmacol,2021,12:734539.
[37] 候宁,吴东雪,刘敏,等.基于药性组合的丹参和红花的性效关系研究[J].中国中药杂志,2019,44(2):224-228.
[38] 张罡瑜,何琪,林瑞婷,等.基于网络药理学的“丹参-红花药对”抗骨质疏松分子机制研究[J].华中科技大学学报(医学版),2021,50(3):284-291.
相似文献/References:
[1]王亮,王予彬,汤华林.肩袖损伤和创伤性肩关节前方不稳定患者肩部疼痛
与肩峰下滑囊组织中炎症反应的关系研究[J].中医正骨,2015,27(10):5.
WANG Liang,WANG Yubin,TANG Hualin.Study on the relationship between shoulder pain and inflammatory reaction in the subacromial bursa tissues in patients with rotator cuff injury and traumatic shoulder joint anterior instability[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(06):5.
[2]李林军.应用膨胀式椎弓根螺钉内固定治疗合并骨质疏松的
胸腰椎退行性疾病[J].中医正骨,2015,27(08):49.
[3]韩艳,温利平,刘娜,等.补肾活血方对去卵巢大鼠骨代谢及骨密度的影响[J].中医正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(补肾活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(06):7.
[4]李学朋,朱立国.骨疏康胶囊对去卵巢大鼠骨小梁的影响[J].中医正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康胶囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(06):12.
[5]陈冠军,陈扬,庄汝杰.可灌注骨水泥椎弓根螺钉系统
在老年腰椎疾患手术中的应用[J].中医正骨,2015,27(02):40.
[6]王丹辉,贲越,韩梅.林蛙油治疗绝经后骨质疏松症的临床研究[J].中医正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(06):27.
[7]黄建华,黄建武,李慧辉,等.加味左归丸对绝经后骨质疏松症肝肾不足证
患者骨密度的影响[J].中医正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(06):19.
[8]项旻,杨虹,林爱菊,等.绝经后2型糖尿病患者骨质疏松与血微量元素的关系研究[J].中医正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(06):20.
[9]史晓林,李春雯,张志强.弱阳离子磁珠分离技术和基质辅助激光解吸电离飞行时间质谱技术在原发性Ⅰ型骨质疏松症血清标志蛋白筛选中的应用[J].中医正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(06):5.
[10]李明,徐明雄,冯左基,等.自拟壮骨方治疗绝经后骨质疏松症的疗效及作用机制研究[J].中医正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(06):21.
[11]杨庆贤,曹翠萍,曹哲.常规抗骨质疏松疗法联合腰腹肌训练治疗原发性骨质疏松腰背部疼痛[J].中医正骨,2017,29(06):72.